1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015" provides data on the Keratoconjunctivitis sicca (Dry Eye) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Keratoconjunctivitis sicca (Dry Eye). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Keratoconjunctivitis sicca (Dry Eye). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2015
Introduction 6
Keratoconjunctivitis sicca (Dry Eye) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Keratoconjunctivitis sicca (Dry Eye) 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novartis AG 33
Clinical Trial Overview of Novartis AG 33
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37
Santen Pharmaceutical Co., Ltd. 40
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 40
Valeant Pharmaceuticals International, Inc. 42
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 42
Innovative Medical Products 43
Clinical Trial Overview of Innovative Medical Products 43
Otsuka Holdings Co., Ltd. 44
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 44
Merck and Co., Inc. 45
Clinical Trial Overview of Merck and Co., Inc. 45
ORA, Inc. 46
Clinical Trial Overview of ORA, Inc. 46
Pfizer Inc. 47
Clinical Trial Overview of Pfizer Inc. 47
Laboratoires Thea S.A. 48
Clinical Trial Overview of Laboratoires Thea S.A. 48
Clinical Trial Overview of Top Institutes / Government 49
Kyoto Prefectural University of Medicine 49
Clinical Trial Overview of Kyoto Prefectural University of Medicine 49
Keio University 50
Clinical Trial Overview of Keio University 50
University of Texas Southwestern Medical Center at Dallas 51
Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 51
Marshall B. Ketchum University 52
Clinical Trial Overview of Marshall B. Ketchum University 52
Federal University of Sao Paulo 53
Clinical Trial Overview of Federal University of Sao Paulo 53
Massachusetts Eye and Ear Infirmary 54
Clinical Trial Overview of Massachusetts Eye and Ear Infirmary 54
Ophthalmic Consultants of Long Island 55
Clinical Trial Overview of Ophthalmic Consultants of Long Island 55
Instituto Universitario de Oftalmobiología Aplicada 56
Clinical Trial Overview of Instituto Universitario de Oftalmobiología Aplicada 56
Wenzhou Medical College 57
Clinical Trial Overview of Wenzhou Medical College 57
Marui Eye Clinic 58
Clinical Trial Overview of Marui Eye Clinic 58
Five Key Clinical Profiles 59
Appendix 83
Abbreviations 83
Definitions 83
Research Methodology 84
Secondary Research 85
About GlobalData 85
Contact Us 85
Disclaimer 85
Source 86

List of Tables

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region, 2015* 7
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 33
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015* 37
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 40
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 42
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovative Medical Products, 2015* 43
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 44
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 45
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by ORA, Inc., 2015* 46
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 47
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015* 48
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 49
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015* 50
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015* 51
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Marshall B. Ketchum University, 2015* 52
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 53
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts Eye and Ear Infirmary, 2015* 54
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthalmic Consultants of Long Island, 2015* 55
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto Universitario de Oftalmobiología Aplicada, 2015* 56
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wenzhou Medical College, 2015* 57
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials Market, Global, Clinical Trials by Marui Eye Clinic, 2015* 58

List of Figures

Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Keratoconjunctivitis sicca (Dry Eye) to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Keratoconjunctivitis sicca (Dry Eye) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Keratoconjunctivitis sicca (Dry Eye) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 84

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.